Skip to main content
Clinical Trials/CTRI/2024/06/068299
CTRI/2024/06/068299
Not yet recruiting
Phase 3

Effect of low dose intrathecal morphine as a part of multimodal analgesia in patients undergoing cardiac surgeries through sternotomy – open-label randomized control trial. - Nil

All India Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Medical Sciences
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 to 65 years undergoing midline sternotomy for cardiac surgeries, New York Heart Association grade II\-III patients

Exclusion Criteria

  • Patient refusal to consent, contraindications to intrathecal analgesia such as infection at the injection site, coagulopathy,
  • and allergy to morphine, pre\-existing chronic pain: taking routine analgesics, patients with a history of chronic opiate abuse, patients with psychiatric disorders, patients with previous surgery in thoracic vertebral region, preexisting neurological condition (spinal cord injury, multiple sclerosis, etc.), patients with BMI more than or equal to 35, patients with severe respiratory disease, those expected to be on elective mechanical ventilation for more than 6 hours postoperatively, patients with renal dysfunction (Serum creatinine more than 1\.5 mg/dl).

Outcomes

Primary Outcomes

Not specified

Similar Trials